From Nasdaq: 2024-07-26 11:00:58

Investing in small-cap stocks can offer growth potential but comes with higher volatility. Tom Lee, head of research at Fundstrat Global Advisors, believes small-cap stocks will gain around 50% in 2024 citing five key reasons. The Russell 2000 Index has gained over 10% year-to-date, showing promise for this sector of the market.

ChargePoint Holdings (CHPT) is a key player in the EV charging infrastructure market with a stock value of $859.4 million. The company is currently unprofitable due to significant investments in network expansion and technology. However, analysts expect net losses to decrease in fiscal 2025 and revenue to increase by double digits in fiscal 2026.

Viridian Therapeutics (VRDN) is valued at $1.04 billion and focuses on treating rare diseases like thyroid eye disease. Analysts foresee an upside potential of about 115% over the next 12 months, given the company’s innovative approach to developing therapies for this niche market.

Soleno Therapeutic (SLNO) is valued at $1.56 billion and is dedicated to developing treatments for Prader-Willi syndrome. The company’s lead product candidate, DCCR, is undergoing Phase 3 clinical trials and has received a Breakthrough Therapy designation from the FDA, showing promise for future growth.



Read more at Nasdaq: 3 Top Small-Cap Tech Picks for Investors This Month